Non-opioid Pain Patch Market Share

  • Report ID: 5423
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Non-opioid Pain Patch Market Share

North American Market Forecast

Non-opioid pain patch market in North America is predicted to account for the largest share of 51% by 2037 propelled by the presence of key players which has led to the development of new products. For instance, in October 2020 Vizuri Health Sciences Consumer Healthcare Inc. an innovative healthcare facility in Maryland, USA, launched a groundbreaking New Pain Relief PatchBloc24 Flexi-Stretch Pain Tape with 4-way stretch fabric and potent anesthetic to numb the pain, making it perfect for use on moving joints, including elbows and knees.

European Market Statistics

The Europe non-opioid pain patch market is estimated to be the second largest, during the forecast timeframe led by a higher prevalence of stress. For instance, Greece has over 6% frequency of depression in Europe, and more than 55% of people in the country are reported to have frequent stress. This may drive the demand for non-opioid pain patch in the region since people with stress usually experience migraine which causes pain behind one eye or in the area surrounding the temples and lasts for hours or days.

Research Nester
Non-opioid-Pain-Patches-Market-size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5423
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion.

The non-opioid pain patch market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. Growing burden of diabetes across the globe and The growing development of advanced products will drive the market growth.

North America industry is likely to dominate majority revenue share 51% by 2037, impelled by presence of key players which has led to the development of new products in the region.

The major players in the market are GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample